The signals are always there — 4–6 weeks before escalation. Praeveo reads them automatically.
Lead CRAs spread across parallel trials, capacity gaps undetected until week 8. By then, site visits are missed and monitoring backlogs compound silently across your entire program.
Site enrollment dropping 30%+ below plan, visible in data but buried in spreadsheets. Nobody connects the dots until the quarterly review reveals months of lost time.
Document backlogs and review delays compounding silently. Protocol amendments trigger cascading resubmissions that push timelines weeks beyond the original plan.
Four AI-powered signal categories — reading your trial data continuously.
Detects when CRAs are overallocated across parallel trials, flagging capacity gaps before they impact site monitoring schedules and data quality.
Resource · Cross-trialContinuously compares actual enrollment against protocol targets at every site, detecting slowdowns 4–6 weeks before they show up in quarterly reviews.
Enrollment · Per-siteTracks the frequency and cascade effect of protocol amendments, identifying when amendment velocity exceeds historical baselines for similar trials.
Regulatory · TrendMonitors the rate of document submission vs. review completion, alerting when backlog growth patterns match historically delayed regulatory submissions.
Compliance · Predictive30 seconds — and we'll get back to you within 24 hours. No sales pitch, just an honest conversation about your clinical operations challenges.
Book a conversation →